A woman came into triage with her 6-week-old baby, terrified. She had little support at home and was worried about caring for ...

The Trump administration can slash $783 million of research funding in its push to cut federal diversity, equity and ...

On September 10, join this virtual event to hear industry-leading insights to improve operational efficiency and regulatory ...

A major U.S. drug manufacturing plant did not properly investigate cat hair, pests, and other problems, the FDA found in a ...

The shooter, identified by authorities as Patrick Joseph White, appears to have been captured in security camera footage ...

This week on "The Readout LOUD," we discuss Viking Therapeutics' obesity flop and dish on the growing "pharm to table" movement.

Epic Systems announced a bevy of new AI products at the annual meeting for its EHR customers this week, including an AI scribe and AI assistants aimed at clinicians, patients, and admin staff. My ...

Ionis Pharmaceuticals won FDA approval for a drug that prevents painful swelling attacks triggered by a rare genetic ...

Morning. Today, we see fallout from the FDA’s rejection of Replimune’s melanoma drug affecting another biotech, learn how Sarepta’s decision-making has affected a patient population that hasn’t always ...

CVS Health will not add Gilead Sciences' new HIV prevention drug to its commercial plans for now, despite the medicine's proven effectiveness ...

The FDA has agreed to speed up a review of a rare disease drug developed by Stealth BioTherapeutics, a notable step after the company said it may have to close its doors otherwise.

Good morning. We've got a meaty issue for you today. In particular, I urge you to spend some time with Jason Mast's story. It's another heartbreaking ...